Clinics in Dermatology
Volume 27, Issue 2 , Pages 195-201 , March 2009

Lutein and zeaxanthin in eye and skin health

References 

  1. Szabolcs J. Plant carotenoids in carotenoids: chemistry and biology. In:  Krinsky NI,  Mathews-Roth MM,  Taylor RF editor. New York: Plenum Press; 1990;p. 39–58
  2. Goulinet S, Chapman MJ. Plasma LDL and HDL subspecies are heterogenous in particle content of tocopherols and oxygenated and hydrocarbon carotenoids. Relevance to oxidative resistance and atherogenesis. Arterioscler Thromb Vasc Biol. 1997;17:786–796
  3. Sujak A, Gabrielska J, Grudzinski W, Borc R, Mazurek P, Gruszecki W. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: the structural aspects. Arch Biochem Biophys. 1999;371:301–307
  4. Sujak A, Okulski W, Gruszecki W. Organisation of xanthophyll pigments lutein and zeaxanthin in lipid membranes formed with dipalmitoylphosphatidylcholine. Biochim Biophys Acta. 2000;1509:255–263
  5. Khachik F, Nir Z, Ausich R, Steck A, Pfander H. Distribution of carotenoids in fruits and vegetables for the selection of appropriate chemopreventative factors. Proceedings of the International Conference on Food Factors, Chem Cancer Prev. 1995;204–208
  6. Sommerburg O, Keunen J, Bird A, van Kuijk F. Fruits and vegetables that are sources of lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol. 1998;82:907–910
  7. Chung H, Rasmussen H, Johnson E. Lutein bioavailability is higher from lutein-enriched eggs than form supplements and spinach in men. J Nutr. 2004;134:1887–1893
  8. Khachik F, Beecher G, Goli M, Lusby W. Separation and quantitation of carotenoids in foods. Methods Enzymol. 1992;213:347–359
  9. Khachik F, Beecher G, Goli M, Lusby W, Smith J. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem. 1992;64:2111–2122
  10. Cooper D, Eldridge A, Peters J. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: a review of recent research. Nutr Rev. 1999;57:201–214
  11. Guigliano D. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovasc Dis. 2000;10:38–44
  12. Goldberg J, Flowerdew G, Smith E, Brody J, Tso M. Factors associated with age-related macular degeneration. An analysis of data from the first National Health and Nutritional Examination Survey. Am J Epidemiol. 1988;128:700–710
  13. Eye Disease Case Control Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol. 1993;111:104–109
  14. Jaques P. The potential role of preventive effects of vitamins for cataract and age-related macular degeneration. Int J Vitam Nutr Res. 1999;69:198–205
  15. Moeller S, Jacques P, Blumberg J. The potential role of dietary xanthophylls in cataract and age-related macular degeneration. J Am Coll Nutr. 2000;19:522S–527S
  16. Slattery M, Benson J, Curtin K, Ma K, Schaeffer D, Potter J. Carotenoids and colon cancer. Am J Clin Nutr. 2000;71:575–582
  17. Ziegler R, Mayne S, Swanson C. Nutrition and lung cancer. Cancer Causes Control. 1996;7:157–177
  18. Kritchevsky S. Beta-carotene, carotenoids, and the prevention of coronary heart disease. J Nutr. 1999;129:5–8
  19. DelCourt C, Carriere I, Delage M, Barberger-Gateau P, Schalch W. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataracts: the POLA study. Invest Ophthalmol Vis Sci. 2006;47:2329–2335
  20. Able R. In: The eye care revolution: prevent and reverse vision problems. New York: Kensington Books; 1999;p. 41–46
  21. Ham W, Mueller H, Sliney D. Retinal sensitivity to damage from short wavelengths of light. Nature. 1976;260:153–155
  22. Beatty S, Boulton M, Henson D, Koh H, Murray I. Macular pigment and age-related macular degeneration. Br J Ophthalmol. 1999;83:867–877
  23. Beatty S, Nolan J, Kavanagh H, O'Donovan . Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430:70–76
  24. Koh H, Murray I, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004;79:21–27
  25. Krinsky N, Landrum J, Bone R. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171–201
  26. Ruffolo J, Ham T, Mueller H, Millen J. Photochemical lesions in the primate retina under controlled conditions of elevated blood oxygen. Invest Ophthalmol Vis Sci. 1984;25:893–898
  27. Handelman G, Dratz E, Reay C, van Kuijk J. Carotenoids in the human macula and whole retina. Invest Ophthalmol Vis Sci. 1988;29:850–855
  28. Bone R, Landrum J, Tarsis S. Preliminary identification of the human macular pigment. Vis Res. 1985;25:1531–1535
  29. Snodderly D, Handelman G, Adler A. Distribution of individual macular pigment carotenoids in central retina of macaque and squirrel monkeys. Invest Ophthalmol Vis Sci. 1991;32:268–279
  30. Bone R, Landrum J. Distribution of macular pigment components, zeaxanthin and lutein, in human retina. Methods Enzymol. 1991;213:360–366
  31. Landrum J, Bone R. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28–40
  32. Bone R, Landrum J, Friedes L, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211–218
  33. Mares-Perlman J, Millen A, Ficek T, Hankinson S. The body of evidence to support a protective role for lutein and zeaxanthin in delaying chronic diseases. Overview. J Nutr. 2002;132:518S–524S
  34. Klaver C, Wolfs R, Vingerling J, Hofman J, de Jong P. Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam Study. Arch Ophthalmol. 1998;116:653–658
  35. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115–134
  36. Fine S, Berger J, Maguire M, Ho A. Age-related macular degeneration. N Engl J Med. 2000;342:483–492
  37. Johnson E. Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev. 2005;63:9–15
  38. Klein R, Zeiss C, Chew E, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385–389
  39. Christen W. Antioxidant vitamins and age-related eye diseases. Proc Assoc Am Physicians. 1999;111:16–21
  40. Cai J, Nelson K, Wu M, Sternberg P, Jones D. Oxidative damage and protection of RPE. Prog Retin Eye Res. 2000;19:205–221
  41. Seddon J, Anani A, Sperduto R, et al. Dietary carotenoids, vitamin A, C, E and advanced age-related macular degeneration. Eye Disease Case Controlled Study Group. JAMA. 1994;272:1413–1420[published erratum appears in JAMA 273 (1995) 6221]
  42. Moeller S, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006;124:1151–1162
  43. Bone R, Landrum J, Mayne S, Gomez C, Tibor S, Twaroska E. Macular pigment in donor eyes with and without AMD: a case-controlled study. Invest Ophthalmol Vis Sci. 2001;42:235–240
  44. Hammond B, Johnson E, Russell R, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 2000;41:3322–3326
  45. Johnson E, Hammond B, Yeum K, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555–1562
  46. Berendschot T, Goldbohm R, Klopping W, et al. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322–3326
  47. Landrum J, Bone R, Joa H, Kilburn M, Moore L, Sprague K. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57–62
  48. Landrum J. Serum and macular pigment response to 2.4 mg dosage of lutein. ARVO. 2000;2000:41
  49. Nolan J, Stack J, Mellerio J, et al. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res. 2006;31:199–213
  50. Richer S. ARMD–pilot (case series) environmental intervention data. J Am Optom Assoc. 1999;70:24–36
  51. Massacesi A, Faletra R, Gerosa G, Staurenghi G, Orzalesi N. The effect of oral supplementation of macular carotenoids (lutein and zeaxanthin) on the prevention of age-related macular degeneration: an 18-month follow-up study. ARVO. 2001;42:S234
  52. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atopic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216–230
  53. Kvansakul J, Rodriguez-Carmona M, Edgar D, et al. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt. 2006;26:362–371
  54. Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked, placebo-controlled clinical trial [NCT00029289]. BMC Ophthalmol. 2006;6:23
  55. Kochevar I, Pathak M, Parrish J. Photophysics, photochemistry and photobiology. In:  Freedberg IM,  Eisen AZ,  Wolff K, et al. editor. Fitzpatrick's dermatology in general medicine. 5th ed.. New York: McGraw-Hill; 1999;p. 220–229
  56. Greenstock C. Radiation-induced aging an induction and promotion of biological damage in free radicals, aging, and degenerative diseases. In:  Johnson JE,  Walford R, et al. editor. New York: AR Liss Inc; 1986;p. 197–219
  57. Fuchs J, Mehlhorn R, Packer L. Free radical reduction mechanisms in mouse epidermis skin homogenates. J Invest Dermatol. 1989;93:633–640
  58. Fuchs J, Huflejt M, Rothfuss L, Wilson D, Carcamo G, Packer L. Impairment of enzymatic and nonenzymatic antioxidants in skin by UVB irradiation. J Invest Dermatol. 1989;93:769–773
  59. Fuchs J, Huflejt M, Rothfuss L, Wilson D, Carcamo G, Packer L. Acute effects of near ultraviolet and visible light on cutaneous antioxidant defense system. Photochem Photobiol. 1989;50:739–744
  60. Shindo Y, Witt E, Han D, Packer L. Dose-response effects of acute ultraviolet irradiation on antioxidants and molecular markers of oxidation in murine epidermis and dermis. J Invest Dermatol. 1994;102:470–475
  61. Jurkiewicz-Lange B, Buettner G. Electron paramagnetic resonance detection of free radicals in UV-irradiated human and mouse skin. In:  Thiele J,  Elsner P editor. Oxidants and antioxidants in cutaneous biology: current problems in dermatology. vol. 29:Basel: Karger; 2001;p. 18–25
  62. Sayre R, Kollias N, Roberts R, Baqer A, Sadiq I. Physical sunscreens sunscreens sunscreens sunscreens. J Soc Cosmet Chem. 1990;41:103–109
  63. Wingerath T, Seis H, Stahl W. Xanthophyll esters in human skin. Arch Biochem Biophys. 1998;355:271–274
  64. Hata T, Scholz T, Ermakov I, et al. Non-invasive Raman spectroscopic detection of carotenoids in human skin. J Invest Dermatol. 2000;115:441–448
  65. González S, Astner S, Wu A, Goukassian D, Pathak M. Dietary lutein/zeaxanthin decreases ultraviolet B-induced epidermal hyperproliferation and acute inflammation in hairless mice. J Invest Dermatol. 2003;121:399–405
  66. Lee E, Faulhaber D, Hanson K, et al. Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression. J Invest Dermatol. 2004;122:510–517
  67. Morganti P, Bruno C, Guarneri F, Cardillo A, Del Ciotto P, Valenzano F. Role of topical and nutritional supplements to modify the oxidative stress. Int J Cosmet Sci. 2002;24:331–339
  68. Rice-Evans C, Sampson J, Bramley P, Holloway D. Why do we expect carotenoids to be antioxidants in vivo?. Free Radic Res. 1997;26:381–398
  69. Krinsky N. Carotenoid protection against oxidation. Pure Appl Chem. 1979;51:649–660
  70. Krinsky N, Deneke S. Interaction of oxygen and oxy-radicals with carotenoids. J Natl Cancer Inst. 1982;69:205–210
  71. DiMascio P, Devasagayam T, Kaiser S, Sies H. Carotenoids, tocopherols and thiols as biological singlet oxygen quenchers. Biochem Soc Trans. 1990;18:1054–1056
  72. Miki W. Biological functions and activities of animal carotenoids. Pure Appl Chem. 1991;63:141–146
  73. Terao J, Nagao A, Park D-K, Lim B. Lipid hydroperoxide assay for antioxidant activity of carotenoids. Methods Enzymol. 1992;213:454–460
  74. Chopra M, Wilson R, Thurnham S. Free radical scavenging of lutein in vitro. Ann N Y Acad Sci. 1993;691:246–249
  75. Miller N, Sampson J, Candeias L, Bramley B, Rice-Evans C. Antioxidant activities of carotenes and xanthophylls. FEBS Lett. 1996;384:240–242
  76. Black H. Radical interception by carotenoids and effects on UV carcinogenesis. Nutr Cancer. 1998;31:212–217
  77. Krinsky N. The antioxidant and biological properties of the carotenoids. Ann N Y Acad Sci. 1998;854:443–447
  78. Edge R, Truscott T. Carotenoid radicals and the interaction of carotenoids with active oxygen species. In:  Frank HA,  Young AJ,  Britton G,  Cogdell RJ editor. The photochemistry of carotenoids. The Netherlands: Kluwer Academic Publishers; 1999;p. 223–234
  79. Krinsky N. Possible biologic mechanism for a protective role of xanthophylls. J Nutr. 2002;132:540S–542S
  80. Danno K, Horio T, Takigawa M, Imamura S. Role of oxygen intermediates in UV-induced epidermal cell injury. J Invest Dermatol. 1984;83:166–168
  81. Steenvoorden D, Beijersbergen van Henegouwen G. The use of endogenous antioxidants to improve photoprotection. J Photochem Photobiol B: Biology. 1997;41:1–10
  82. Palombo P, Fabrizi G, Ruocco V, et al. New evidence of lutein/zeaxanthin in skin health. In: Beyond Beauty Paris Conference, Paris. 2006;[Abstract]

PII: S0738-081X(08)00012-6

doi: 10.1016/j.clindermatol.2008.01.011

Clinics in Dermatology
Volume 27, Issue 2 , Pages 195-201 , March 2009

Article Tools

* Image Usage & Resolution